Vanderbilt Ingram Cancer Center

Vandana Abramson, M.D., assistant professor of Medicine and a breast cancer specialist at Vanderbilt-Ingram Cancer Center, has received the Advanced Clinical Research Award in Breast Cancer from the Conquer Cancer Foundation (CCF). Read More

Jennifer Pietenpol, Ph.D., B.F. Byrd Jr. Professor of Oncology and director of Vanderbilt-Ingram Cancer Center, has been named an at-large member of the National Cancer Policy Forum, an advisory group of the Institute of Medicine (IOM) of the National Academies. Read More

Vanderbilt continues to win recognition for its commitment to helping employees stay healthy, including support for activities that may protect against cancer. Vanderbilt University Medical Center (VUMC), in conjunction with Vanderbilt-Ingram Cancer Center (VICC), has been re-accredited as a CEO Cancer Gold Standard employer for 2014. In 2001, former President… Read More

New Vanderbilt research suggests patients with advanced melanoma — the most deadly form of skin cancer — could safely benefit from a combination of immunotherapy and targeted therapies aimed at specific gene mutations. Read More

My Cancer Genome, an online precision cancer medicine tool developed by researchers at Vanderbilt-Ingram Cancer Center, has unveiled an updated free mobile app that provides even more information about genetic alterations in various types of cancer and the therapies available to treat those alterations. Read More

Unique molecular "fingerprints" could explain the disparity in Wilms tumor incidence and point to novel, race-specific therapeutic targets. Read More

Using enhanced gene mutation testing to provide precision therapy for cancer patients was one of the themes at the annual Vanderbilt-Ingram Cancer Center (VICC) scientific retreat, held May 15 at the Vanderbilt Student Life Center. Read More

The contractile machinery inside tumor cells increases invasive properties, suggesting it might be a good target to inhibit cancer cell spread. Read More

Music will set the tone for Vanderbilt-Ingram Cancer Center’s annual Cancer Survivorship Celebration for patients, friends and families. Read More

A novel PET imaging probe detects tumor cell death in vivo and could be useful for personalizing cancer medicine. Read More

Sarah Rohde, M.D., assistant professor of Otolaryngology, examines Steve Corbitt for signs of head and neck cancer. Vanderbilt-Ingram Cancer Center and the Vanderbilt Department of Otolaryngology held the annual head and neck cancer screening event April 25. During the free and fast exams, physicians inspect the mouth… Read More

A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication. Read More

A retired elementary school principal has become the first patient at Vanderbilt-Ingram Cancer Center to receive an investigational cancer therapy for the treatment of his neuroendocrine tumor. Read More

Research led by Joan Garrett, Ph.D., research instructor in Hematology/Oncology, reveals a molecular mechanism that may explain why some forms of breast cancer become resistant to therapy. Read More

Carlos L. Arteaga, M.D., professor of Medicine and Cancer Biology and Donna S. Hall Professor of Breast Cancer Research at Vanderbilt-Ingram Cancer Center (VICC), assumed the presidency of the American Association for Cancer Research (AACR) for 2014-2015 during the group’s annual meeting last week in San Diego. Read More

Vanderbilt-Ingram Cancer Center and the Vanderbilt Department of Otolaryngology will hold the annual head and neck cancer screening event Friday, April 25, 9 a.m. – 3 p.m. The screenings are free, open to the public and require no appointment. Read More

The Allstate WBCA Good Works Team partnered with the Kay Yow Cancer Fund to distribute wellness kits to patients at the Vanderbilt-Ingram Cancer Center this week to celebrate the NCAA Division 1 Women’s Basketball Championship held in Nashville. Read More

The FTL Sarcoma Fund, in partnership with the T.J. Martell Foundation, recently presented a gift to the Vanderbilt-Ingram Cancer Center in support of sarcoma research in memory of Warner Music Nashville colleague Lindsay Walleman. Read More

Scott Hiebert, Ph.D., associate director of Basic Research at Vanderbilt-Ingram Cancer Center (VICC), was celebrated for his contributions to cancer research during the 6th Annual Nashville Honors Gala benefiting the T.J. Martell Foundation. Read More

Vanderbilt researchers have discovered small molecules that turn off cancerous Ras signals in a new way. Read More